Loading clinical trials...
Loading clinical trials...
The Long Term Effects of Alfuzosin (Xatral XL) in LUTS/BPH Patients: Evaluation of Symptom-specific Goal Achievement According to Symptom Improvement, Bladder Outlet Obstruction Grade and Bladder Contractility
Conditions
Interventions
Alfuzosin
Locations
2
South Korea
Asan Medical Center, Ulsan College of Medicine
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Start Date
December 1, 2005
Primary Completion Date
August 1, 2008
Completion Date
August 1, 2008
Last Updated
November 1, 2023
NCT07451548
NCT07016620
NCT06312722
NCT06817733
NCT03802851
NCT06265519
Lead Sponsor
Samsung Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions